Scottsdale, Arizona (February 13, 2020) – Healthcare Trust of America, Inc. (NYSE: HTA) (“HTA”) announced results for the quarter and year ended December 31, 2019. “In 2019, HTA grew its best-in-class portfolio with strategic accretive investments in key markets, while continuing to build strong tenant and health system relationships and strategic partnerships,” stated Chairman, CEO and […]
SCOTTSDALE, ARIZONA, February 13, 2020 – Healthcare Trust of America, Inc. (NYSE:HTA), the largest dedicated owner and operator of medical office buildings in the United States, announced today that its board of directors issued a quarterly dividend of $0.315 per share of common stock. This represents an annualized rate of $1.26 per share of common […]
SCOTTSDALE, ARIZONA—January 29, 2020— Healthcare Trust of America, Inc. (NYSE:HTA), the largest dedicated owner and operator of medical office buildings in the United States, announced today that on Thursday, February 13, 2020, after the market closes, HTA will report its financial results for the three months ending December 31, 2019. The Company also plans to […]
SCOTTSDALE, ARIZONA, January 16, 2020 – Healthcare Trust of America, Inc. (NYSE:HTA or the “Company”), announced today the release of its inaugural Sustainability Report. The report outlines the Company’s commitment and progress towards goals related to environmental, social and governance (“ESG”) matters. Though it is the first report, HTA has been committed to its ethos, […]
SCOTTSDALE, ARIZONA, January 9, 2020 – Healthcare Trust of America, Inc. (NYSE:HTA or the “Company”), announced today that its Board of Directors has appointed Mr. H. Lee Cooper and Mr. Jay P. Leupp as new Independent Directors of the Board. In addition, the Company announced the resignation of current director Mr. Daniel S. Henson. Mr. […]
Scottsdale, Arizona (October 28, 2019) – Healthcare Trust of America, Inc. (NYSE: HTA) (“HTA”) announced results for the three and nine months ended September 30, 2019. HTA’s Q3 2019 results consist of a net loss attributable to common stockholders of $(0.04) per diluted share, which included a ($0.10) per share charge related to the refinancing of […]